Krysteva M A, Mazurier J, Spik G
Biochim Biophys Acta. 1976 Dec 22;453(2):484-93. doi: 10.1016/0005-2795(76)90144-6.
In order to determine the conformational relationship of iron binding of human serotransferrin and lactotransferrin, ultraviolet difference spectral studies were performed in the presence of guanidine chloride and perturbants as deuterium oxide, ethylene glycol, glycerol and polyethylene glycol. In the presence of guanidine chloride solution the molar absorption differences at 292 nm of iron-saturated forms versus iron-free forms of human serotransferrin and lactotransferrin are respectively -16000 +/- 1000 and -14000 +/- 775. These modifications may be attributed to the involvement of tryptophan residues in the iron-binding sites of the two proteins. However, the results do not demonstrate that these tryptophan residues are bound directly to iron. Difference spectral studies in the presence of perturbants show that the apparent exposed tryptophan and tyrosine residues are higher with shorter range perturbants in iron-free forms of both transferrin molecules. The most important modification of exposed tyrosine residues has been noticed upon removing iron from human lactotransferrin than from serotransferrin.
为了确定人血清转铁蛋白和乳铁蛋白铁结合的构象关系,在存在氯化胍和诸如重水、乙二醇、甘油及聚乙二醇等扰动剂的情况下进行了紫外差光谱研究。在氯化胍溶液存在下,人血清转铁蛋白和乳铁蛋白的铁饱和形式与无铁形式在292nm处的摩尔吸收差异分别为-16000±1000和-14000±775。这些变化可能归因于色氨酸残基参与了这两种蛋白质的铁结合位点。然而,结果并未表明这些色氨酸残基直接与铁结合。在存在扰动剂的情况下进行的差光谱研究表明,在两种转铁蛋白分子的无铁形式中,较短范围的扰动剂会使表观暴露的色氨酸和酪氨酸残基含量更高。从人乳铁蛋白中去除铁时,比从血清转铁蛋白中去除铁时,暴露的酪氨酸残基发生的最重要变化已被注意到。